|
Volumn 42, Issue 2, 2003, Pages 235-239
|
Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): Clinical and laboratory findings in a series of seven patients
|
Author keywords
Etanercept; p55TNFr Ig; Tumour necrosis factor associated periodic syndrome
|
Indexed keywords
AZATHIOPRINE;
COLCHICINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
ETANERCEPT;
HYBRID PROTEIN;
IMMUNOGLOBULIN;
IMMUNOMODULATING AGENT;
INFLIXIMAB;
METHOTREXATE;
METHYLPREDNISOLONE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREDNISOLONE;
PROTEIN P55;
TACROLIMUS;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA RECEPTOR;
TUMOR NECROSIS FACTOR RECEPTOR 1;
ACUTE PHASE RESPONSE;
ADULT;
AMYLOIDOSIS;
ARTICLE;
AUTOSOMAL DOMINANT DISORDER;
CASE STUDY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DRUG EFFECT;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GENE MUTATION;
HUMAN;
LABORATORY TEST;
MALE;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PROTEIN FAMILY;
SCORING SYSTEM;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;
ADULT;
ANTIGENS, CD;
ANTIRHEUMATIC AGENTS;
C-REACTIVE PROTEIN;
CHILD, PRESCHOOL;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FAMILIAL MEDITERRANEAN FEVER;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOGLOBULIN G;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;
TREATMENT OUTCOME;
|
EID: 0037295409
PISSN: 14620324
EISSN: None
Source Type: Journal
DOI: 10.1093/rheumatology/keg070 Document Type: Article |
Times cited : (187)
|
References (8)
|